Artificial Membrane Binding Protein technology for cell therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
100,000
NCT07128966
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
Phase: N/A
Role: Lead Sponsor
Start: Sep 1, 2025
Completion: Sep 1, 2036
Loading map...